about
Gestational Diabetes Mellitus and Future Cardiovascular Risk: An UpdatePossible role of fructosamine 3-kinase genotyping for the management of diabetic patients.Urinary peptides as a diagnostic tool for renal failure detected by matrix-assisted laser desorption/ionisation mass spectrometry: an evaluation of their clinical significance.The emerging role of telemedicine in managing glycemic control and psychobehavioral aspects of pregnancy complicated by diabetes.Glucose Fluctuations during Gestation: An Additional Tool for Monitoring Pregnancy Complicated by Diabetes.Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes.Pregnancy and foetal outcome after bariatric surgery: a review of recent studies.Genetic variability of the fructosamine 3-kinase gene in diabetic patients.Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes.Role of glycemic variability in gestational diabetes mellitus (GDM): still an uphill climb.Screening with HbA1c identifies only one in two individuals with diagnosis of prediabetes at oral glucose tolerance test: findings in a real-world Caucasian population.Subclinical diastolic dysfunction in type 2 diabetic patients with and without carotid atherosclerosis: relationship with glyco-oxidation, lipid-oxidation and antioxidant status.The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM)Palpebral ptosis, fixed mydriasis and exophthalmos: an uncommon presentation of new diabetes mellitusEffectiveness of a diet with low advanced glycation end products, in improving glycoxidation and lipid peroxidation: a long-term investigation in patients with chronic renal failureFocusing on potential sources of glucose fluctuations in type 1 and type 2 diabetes: which kind of patient, what kind of glycemic variability and which confounding factors?Between reduction of glucose fluctuations and increased therapeutic adherence: an example of the benefits of vildagliptin in an elderly diabetic patientLong-term effect of pioglitazone vs glimepiride on lipoprotein oxidation in patients with type 2 diabetes: a prospective randomized study
P50
Q28067405-26A6CF85-8249-42E1-9BCA-958C9BB6A3E9Q30378957-6A9ADE97-4EB3-49DD-B155-7F876B5FC72AQ33986978-05FBE77C-056E-4C94-805D-02AE2A1C0F8CQ34253412-5704DC88-7AD2-4131-90B7-A46D7FB6D626Q37351633-B52D2672-EDD5-4875-9FEC-4F837772D090Q37463412-9F79715F-7029-4EC6-8524-C471A242F714Q37984459-EE3B97F8-C8BB-4DD8-A1B7-CB880770D01AQ39787188-DC480038-3200-4B7C-A5B4-A269BCE99A74Q44238141-8D5F89C4-3E1C-4A08-A060-B2B5B2D490DAQ46105803-4D12706C-D98A-4A02-9C37-74C4B9F79F15Q51316218-FCE4FB88-DAB8-467E-BE59-E8369DF2A12AQ51371727-2DCCC4AF-344A-445E-BD56-93D6024C8E14Q83784102-31C0A1E2-0DF0-4817-BFD0-E5F10AC77151Q84831612-65A280D3-61FB-4C51-B14C-0CA4625EB2E3Q86752907-7677B938-138A-4E6E-82A1-C38BA4FB491EQ87589204-A3A9D17D-FA5E-4E50-BA05-59ADF199AE54Q87782459-BBADD0DA-95E8-4E23-A67C-FB05F92AA712Q91444072-32304BB5-0DA7-4E08-A4BC-3B76416B62B1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nino Cristiano Chilelli
@ast
Nino Cristiano Chilelli
@en
Nino Cristiano Chilelli
@es
Nino Cristiano Chilelli
@nl
Nino Cristiano Chilelli
@sl
type
label
Nino Cristiano Chilelli
@ast
Nino Cristiano Chilelli
@en
Nino Cristiano Chilelli
@es
Nino Cristiano Chilelli
@nl
Nino Cristiano Chilelli
@sl
prefLabel
Nino Cristiano Chilelli
@ast
Nino Cristiano Chilelli
@en
Nino Cristiano Chilelli
@es
Nino Cristiano Chilelli
@nl
Nino Cristiano Chilelli
@sl
P106
P21
P31
P496
0000-0003-0941-4691